Benralizumab (Fasenra)
Revision as of 19:54, 27 February 2020 by Warner-admin (talk | contribs) (Text replacement - "Category:Antibody medications" to "")
General information
Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5).
Diseases for which it is used
History of changes in FDA indication
No approval for hematology/oncology conditions, at this time.
Also known as
- Brand names: Fasenra